From March 14 to 18, the 10th Health Industry Ecological Platform (PHCF) was grandly held in Huzhou, Zhejiang. The event brought together tens of thousands of industry professionals and witnessed the announcement of several authoritative awards. Among them, Pudilan Xiaoyan Oral Liquid and Xiao'er Chiqiao Qingre Granules (Tonpei) were both honored as "2024–2025 Best-Selling Brands in China's Pharmaceutical Retail Market", further enhancing their brand influence in the retail sector.

 

 

 

The 10th Health Industry Ecological Platform , guided by the mission of "Making High-Quality Health Products Accessible to All", aims to build China's largest, most comprehensive, and most efficient out-of-hospital health product trading platform with the broadest terminal coverage. The event unveiled the 2024–2025 Best-Selling Brands and Potential Brands in China's Pharmaceutical Retail Market. The selection process, based on core indicators such as brand strength, growth potential, and accessibility, used a scientific data model to comprehensively evaluate the shortlisted brands. By recognizing strong brands, the awards aim to support terminal product selection and promote high-quality development in the retail industry.

 

 

 

 

 

Best-Selling Brands Lead Terminal Market Development: "Best-Selling Brands" refer to leading brands in various categories with extensive retail market coverage, high sales volume, strong penetration, and large customer orders. They serve as a guarantee for high-quality development in the terminal market.

 

Pudilan Xiaoyan Oral Liquid is a unique formulation product of JumpCan Pharmaceutical, offering greater convenience for children and the elderly. It effectively clears heat, detoxifies, reduces swelling, and soothes the throat. Through years of widespread use and validation, the product was approved last year as a dual-status drug (both prescription and over-the-counter). After transitioning to OTC, patients can purchase it offline at pharmacies and online via e-commerce platforms without a prescription, significantly improving accessibility.

 

JumpCan Pharmaceutical's exclusive product, Xiao'er Chiqiao Qingre Granules (Tonpei), is based on a proven formula from over 50 years of medical practice by renowned traditional Chinese medicine expert Professor Li Shaochuan. It is one of the representative medications for pediatric colds. Tongpei's recognition as a "2024–2025 Best-Selling Brand in China's Pharmaceutical Retail Market" reflects its popularity among retail pharmacies and consumers. Additionally, to meet diverse medication needs and enhance the patient experience, Xiao'er Chiqiao Qingre Syrup (K-tonpei) has been successfully approved and launched, further supporting children's health.

 

The inclusion of both products in the "2024–2025 Best-Selling Brands" list demonstrates the widespread trust placed in Pudilan Xiaoyan Oral Liquid and Xiao'er Chiqiao Qingre Granules by retail pharmacies and consumers.

 

Guided by its vision of "Build a joyful and vibrant life together", JumpCan Pharmaceutical stays attuned to changes in the pharmaceutical market and evolving patient needs. By strengthening product layout, brand building, and channel expansion, the company continues to extend the benefits of its branded products to more patients. This dual recognition fully affirms JumpCan Pharmaceutical's product quality, brand development, and channel strategies. Moving forward, JumpCan Pharmaceutical will leverage the power of its exemplary brands, striving to make best-selling products leaders in healthy lifestyles, delivering authentic brand value and upgraded experiences to consumers.